Bank of America’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-100,827
| Closed | -$9.78M | – | 7656 |
|
|
2019
Q3 | $9.78M | Sell |
100,827
-27,088
| -21% | -$2.71M | ﹤0.01% | 2534 |
|
|
2019
Q2 | $13.1M | Sell |
127,915
-29,364
| -19% | -$3.17M | ﹤0.01% | 2266 |
|
|
2019
Q1 | $17.9M | Sell |
157,279
-230,397
| -59% | -$16.9M | ﹤0.01% | 1925 |
|
|
2018
Q4 | $15.2M | Buy |
387,676
+308,273
| +388% | +$13.4M | ﹤0.01% | 1920 |
|
|
2018
Q3 | $4.33M | Sell |
79,403
-4,324
| -5% | -$296K | ﹤0.01% | 3318 |
|
|
2018
Q2 | $6.93M | Buy |
83,727
+40,020
| +92% | +$3.09M | ﹤0.01% | 2823 |
|
|
2018
Q1 | $2.91M | Buy |
43,707
+20,434
| +88% | +$1.18M | ﹤0.01% | 3582 |
|
|
2017
Q4 | $1.2M | Buy |
23,273
+11,554
| +99% | +$830K | ﹤0.01% | 4364 |
|
|
2017
Q3 | $1.04M | Buy |
11,719
+7,124
| +155% | +$541K | ﹤0.01% | 4473 |
|
|
2017
Q2 | $274K | Sell |
4,595
-1,971
| -30% | -$110K | ﹤0.01% | 5172 |
|
|
2017
Q1 | $351K | Sell |
6,566
-3,370
| -34% | -$200K | ﹤0.01% | 5066 |
|
|
2016
Q4 | $496K | Buy |
9,936
+8,987
| +947% | +$481K | ﹤0.01% | 4803 |
|
|
2016
Q3 | $56K | Sell |
949
-1,986
| -68% | -$114K | ﹤0.01% | 5689 |
|
|
2016
Q2 | $150K | Buy |
2,935
+2,880
| +5,236% | +$123K | ﹤0.01% | 5348 |
|
|
2016
Q1 | $2K | Sell |
55
-6,305
| -99% | -$199K | ﹤0.01% | 6813 |
|
|
2015
Q4 | $288K | Buy |
6,360
+3,235
| +104% | +$170K | ﹤0.01% | 5143 |
|
|
2015
Q3 | $131K | Sell |
3,125
-5,093
| -62% | -$266K | ﹤0.01% | 5544 |
|
|
2015
Q2 | $495K | Buy |
8,218
+8,209
| +91,211% | +$543K | ﹤0.01% | 4707 |
|
|
2015
Q1 | $1K | Buy |
+9
| New | +$518 | ﹤0.01% | 6911 |
|
Bank of America's ONCE Position: Q4 2019 in Review
Bank of America sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 100,827 shares — an estimated $9.78M sold.
Bank of America first reported a position in ONCE in Q1 2015 and held it in 19 quarters. The position peaked at $17.9M in Q1 2019. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.
- Bank of America reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
- Bank of America sold 100,827 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $9.78M.
- Bank of America first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 19 quarters.
- Bank of America's Spark Therapeutics, Inc. Common Stock position peaked at $17.9M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.
Based on Bank of America's 13F filing for Q4 2019, filed 14 Feb 2020.